-
mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.
Mol Cell Biol. 2004 Jan;24(1):200-16
PMID: 14673156
-
Insulin regulates transcription of the CCAAT/enhancer binding protein (C/EBP) alpha, beta, and delta genes in fully-differentiated 3T3-L1 adipocytes.
J Biol Chem. 1995 Jan 13;270(2):647-54
PMID: 7822291
-
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.
Nat Cell Biol. 2004 Nov;6(11):1122-8
PMID: 15467718
-
PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
J Biol Chem. 2007 Aug 31;282(35):25604-12
PMID: 17599906
-
Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes.
J Biol Chem. 1980 May 25;255(10):4745-50
PMID: 7372608
-
Identification of Protor as a novel Rictor-binding component of mTOR complex-2.
Biochem J. 2007 Aug 1;405(3):513-22
PMID: 17461779
-
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.
Mol Cell. 2002 Jul;10(1):151-62
PMID: 12150915
-
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.
Oncogene. 2004 Apr 19;23(18):3151-71
PMID: 15094765
-
Stress and mTORture signaling.
Oncogene. 2006 Oct 16;25(48):6373-83
PMID: 17041623
-
Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.
J Biol Chem. 1994 Dec 23;269(51):32027-30
PMID: 7528205
-
Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP.
Science. 1996 Jul 12;273(5272):239-42
PMID: 8662507
-
A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
Cancer Res. 2000 Jul 1;60(13):3504-13
PMID: 10910062
-
mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes.
J Biol Chem. 2005 Dec 9;280(49):40406-16
PMID: 16221682
-
Regulation of TORC1 by Rag GTPases in nutrient response.
Nat Cell Biol. 2008 Aug;10(8):935-45
PMID: 18604198
-
GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR.
Mol Cell. 2003 Apr;11(4):895-904
PMID: 12718876
-
Rheb binds and regulates the mTOR kinase.
Curr Biol. 2005 Apr 26;15(8):702-13
PMID: 15854902
-
Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.
Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R251-8
PMID: 16244323
-
Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.
Mol Cell. 2008 Aug 8;31(3):438-48
PMID: 18691976
-
Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.
Biochem J. 1999 Dec 1;344 Pt 2:427-31
PMID: 10567225
-
PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis.
PLoS One. 2007 Nov 21;2(11):e1217
PMID: 18030348
-
AMPK phosphorylation of raptor mediates a metabolic checkpoint.
Mol Cell. 2008 Apr 25;30(2):214-26
PMID: 18439900
-
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
Nat Cell Biol. 2007 Mar;9(3):316-23
PMID: 17277771
-
Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation.
Curr Biol. 2008 Sep 9;18(17):1269-77
PMID: 18722121
-
Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity.
Genes Dev. 2006 Oct 15;20(20):2820-32
PMID: 17043309
-
Phospholipase D1 is an effector of Rheb in the mTOR pathway.
Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8286-91
PMID: 18550814
-
Phosphatidic acid-mediated mitogenic activation of mTOR signaling.
Science. 2001 Nov 30;294(5548):1942-5
PMID: 11729323
-
Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.
Curr Biol. 2003 Aug 5;13(15):1259-68
PMID: 12906785
-
TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function.
Curr Biol. 2003 May 13;13(10):797-806
PMID: 12747827
-
Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13571-6
PMID: 12271141
-
PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex.
J Biol Chem. 2007 Aug 24;282(34):24514-24
PMID: 17604271
-
The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif.
J Biol Chem. 2003 May 2;278(18):15461-4
PMID: 12604610
-
Defining the role of mTOR in cancer.
Cancer Cell. 2007 Jul;12(1):9-22
PMID: 17613433
-
The two TORCs and Akt.
Dev Cell. 2007 Apr;12(4):487-502
PMID: 17419990
-
Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase.
Oncogene. 2006 Oct 16;25(48):6361-72
PMID: 17041622
-
New insights into mTOR signaling: mTORC2 and beyond.
Sci Signal. 2009 Apr 21;2(67):pe27
PMID: 19383978
-
Identification of a conserved motif required for mTOR signaling.
Curr Biol. 2002 Apr 16;12(8):632-9
PMID: 11967149
-
What controls TOR?
IUBMB Life. 2008 Aug;60(8):483-96
PMID: 18493947
-
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.
Science. 2008 Jun 13;320(5882):1496-501
PMID: 18497260
-
Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status.
J Biol Chem. 2004 Apr 16;279(16):15719-22
PMID: 14970221
-
Mammalian target of rapamycin complex 1 (mTORC1) activity is associated with phosphorylation of raptor by mTOR.
J Biol Chem. 2009 May 29;284(22):14693-7
PMID: 19346248
-
mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s.
Curr Biol. 2006 Sep 19;16(18):1865-70
PMID: 16919458
-
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.
Genes Dev. 2002 Jun 15;16(12):1472-87
PMID: 12080086
-
Two motifs in the translational repressor PHAS-I required for efficient phosphorylation by mammalian target of rapamycin and for recognition by raptor.
J Biol Chem. 2003 May 30;278(22):19667-73
PMID: 12665511
-
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.
Cell. 2002 Jul 26;110(2):177-89
PMID: 12150926
-
The ATRs, ATMs, and TORs are giant HEAT repeat proteins.
Cell. 2003 Jan 24;112(2):151-5
PMID: 12553904
-
Rag proteins regulate amino-acid-induced mTORC1 signalling.
Biochem Soc Trans. 2009 Feb;37(Pt 1):289-90
PMID: 19143648
-
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase.
Mol Cell. 2007 Mar 23;25(6):903-15
PMID: 17386266
-
mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.
Cell. 2002 Jul 26;110(2):163-75
PMID: 12150925
-
Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function.
Genes Cells. 2004 Apr;9(4):359-66
PMID: 15066126
-
Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.
Proc Natl Acad Sci U S A. 1995 May 23;92(11):4947-51
PMID: 7539137
-
Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.
Science. 2007 Nov 9;318(5852):977-80
PMID: 17991864
-
FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions.
J Biol Chem. 2000 Mar 10;275(10):7416-23
PMID: 10702316
-
A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.
Hum Mol Genet. 2002 Mar 1;11(5):525-34
PMID: 11875047
-
Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase.
J Biol Chem. 2005 Jul 15;280(28):26089-93
PMID: 15905173
-
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.
Nat Cell Biol. 2002 Sep;4(9):648-57
PMID: 12172553
-
Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation.
J Biol Chem. 2008 Jun 6;283(23):15619-27
PMID: 18372248
-
Molecular organization of target of rapamycin complex 2.
J Biol Chem. 2005 Sep 2;280(35):30697-704
PMID: 16002396
-
Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase.
J Biol Chem. 2005 Jul 8;280(27):25485-90
PMID: 15899889
-
The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.
J Biol Chem. 2007 Jul 13;282(28):20329-39
PMID: 17517883
-
Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.
Mol Cell. 2003 Jun;11(6):1457-66
PMID: 12820960
-
TSC2 mediates cellular energy response to control cell growth and survival.
Cell. 2003 Nov 26;115(5):577-90
PMID: 14651849
-
Dysregulation of the TSC-mTOR pathway in human disease.
Nat Genet. 2005 Jan;37(1):19-24
PMID: 15624019
-
The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.
Biochem J. 2008 Jun 1;412(2):179-90
PMID: 18466115
-
Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin.
J Biol Chem. 2003 Sep 26;278(39):37288-96
PMID: 12867426
-
mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).
Biochem J. 2008 Dec 15;416(3):375-85
PMID: 18925875
-
Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13489-94
PMID: 15342917
-
Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.
J Biol Chem. 2008 Nov 7;283(45):30482-92
PMID: 18676370
-
Activation of mammalian target of rapamycin (mTOR) by insulin is associated with stimulation of 4EBP1 binding to dimeric mTOR complex 1.
J Biol Chem. 2006 Aug 25;281(34):24293-303
PMID: 16798736
-
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.
Science. 2005 Feb 18;307(5712):1098-101
PMID: 15718470
-
mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer.
Trends Mol Med. 2007 Jun;13(6):252-9
PMID: 17452018
-
Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.
Cell. 2005 Apr 22;121(2):179-93
PMID: 15851026
-
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.
Curr Biol. 2004 Jul 27;14(14):1296-302
PMID: 15268862
-
Molecular mechanisms of mTOR-mediated translational control.
Nat Rev Mol Cell Biol. 2009 May;10(5):307-18
PMID: 19339977
-
TOR signaling in growth and metabolism.
Cell. 2006 Feb 10;124(3):471-84
PMID: 16469695
-
Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms.
Cell Signal. 2009 Jun;21(6):827-35
PMID: 19166929
-
PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding.
J Biol Chem. 2007 Jul 6;282(27):20036-44
PMID: 17510057
-
The pharmacology of mTOR inhibition.
Sci Signal. 2009 Apr 21;2(67):pe24
PMID: 19383975